TDP-43 pathology has been identified in 23–52% of Alzheimer’s disease patients [394,395,396,397] and appears to be concomitant with decreased cognitive function, increased brain atrophy, and memory loss [394]. Here, TARDBP is linked to early-onset autosomal dominant Alzheimer disease.